Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IBX, some great news from an independent blinded review by a panel of expert breast cancer radiologists which has corroborated previously reported positive findings for the company’s MagSense diagnostic tech.
The company says that the radiologists confirmed that the “MagSense HER2 imaging agent produces a change in image contrast and that the contrast in nodes highly suspicious for tumour is distinctly different from the MR image contrast seen in non-involved nodes”.
“The outcome of the independent review is welcome news, indeed,” Imagion Biosystems CEO Bob Proulx said.
“We now have a clear indication that our MagSense magnetic nanoparticle technology could work with the existing medical imaging infrastructure to provide the clinical benefit to breast cancer patients we have been aiming for.
“This takes a lot of the technical risk out of the future and will significantly facilitate market entry by eliminating the need to design, make, sell, and support new machinery.”
It appears that IBX's Magsense is taking a quicker financial road to success by focusing on collaborating with powerhouses like , maybe Siemens MRI, while still continuing work on their own MRX technology independently. We'll know better after their presentation tomorrow...
https://imagionbiosystems.com/news/priority-path-to-market-for-magsense-technology/
As everyone (at least the four of us LOL) knows that I have been harsh on Proulx, and I understand shareholders discontent with the present stock value and the necessity for extra financing, but it's vital to retain the outlook for the far-reaching ramifications of this innovation which I still believe in.
I guess I am feeling rather optimistic these days despite all these silly videos..Fabricating a life-saving contraption necessitates effort and investment, and while the primary 20 cent IPO holders may not immediately see monetary profits, it's essential to think about the bigger picture and the achievable positive effect this technology could have on individuals' lives.
The conclusion of the initial study is a critical turning point and will bring Imagion closer to achieving its aspirations. For now, let's persist in staying optimistic and positive about the future of this firm and its possible influence on humanity. It's not always about money.
Haven't heard a peep about the metals deal (aka manny and marv's latest meal ticket) for quite a while. Correct me if I am wrong, but I think those cash payments are about done. Why no updates from m&m? Running out of cash and price below a penny - maybe the boys have milked this one dry?
Any of you loyal believers spoken to manny or marv recently? Or are they no longer accepting your calls?
Another proulx promo, with not a word about the poor shareholders who paid 20 cents for this now 2 cent stock. Not a word about the need to raise cash or anything he will do to increase shareholder value (fyi, diluting at 2 cents or less to raise $millions is not going to help).
He did reinforce the message that if/when this 1st study is completed there will be a need for a much larger study (fyi, much larger cash requirements). Someday this might be a life saving instrument, but it won't save the financial life on the initial 20 cent ipo holders.
I can't seem to get this Interview to appear on here, but simply copy and view this from 2 days ago...
executive interviews/robert proulx of imagion biosystems
All those low mhtx shares lol. What to do with them with a bid of 8 cents?
Buy low and watch it go lower - not a good investing strategy.
Anyone have an estimate on when ibx will run out of cash? Sometime in 2nd quarter, yes?
A revised patent issued to IBX...
https://patents.justia.com/assignee/imagion-biosystems-inc
If ibx is a legitimate company, proulx should get fired soon. His performance has been despicable. If he remains as ceo, then it is clear this is just another manny and marv type of production. mhtx now below a penny, so good luck with that one too.
Good news coming? Like how much dilution it will take to continue to pay these people? Or maybe, after over 2 years, proulx has managed to find 15 people willing to participate in his disastrous study?
IBX now has 25 workers in San Diego. Did some research on which 10 have been added within last 6 months, 9 within last 1 to 2 years, 3 within 2 to 5 years and 3 since the founding of IBX. Some good news has to be coming.
Kudos for a realistic, no bullshit summary of 2022. Sadly, ibx is just about out of cash and has made very little progress toward commercializing the magsense technology. 2023 will see fund raising at share price near a penny imo and the massive dilution that goes along with it. No promo videos, interviews or luxury living by proulx will change that.
But an even more painful possibility needs to be faced. After more than a decade and many, many millions of dollars, the day of anything meaningful coming out of the ibx lab is still light years away. Why? Either the acquisition of the Flynn technology 12 years ago has been followed by a stream of the most incompetent and/or dishonest leadership imaginable OR the whole thing really just doesn't work.
Consider this p/r from April 2010:
Happy New Year indeed,
2022 has been a difficult year for IBX holders, with the value of their holdings dropping from 8 cents in January to 2.4 cents by December 30th. Despite market conditions, there was little recovery. Shareholders are calling for significant changes in the coming year, including increased communication and potentially a change in leadership. The current CEO Bob Proulx has been criticized as a contributing factor to the decline of the stock and overall, the drop in value has been a significant loss for investors, will the losses continuing.
IF the company wants to cash in on those options still out there, there needs to be some significant announcement, otherwise, things will get crazy as Bob tries to raise anything substantial at this present and dropping stock price.
Get your act together Bob or move out of the way.
Looks like ibx could break below 2 cents soon. How about more interviews and promo videos from proulx? Maybe one from inside his lake tahoe home would really get the stock moving. lmao.
Happy New Year to all those happy owners of ibx shares (now $.023 and heading towards a penny and massive dilution imo), and mhtx shares (now under a penny and nothing but silence from manny and marv - lock them up).
2023 looking like the year both companies run out of cash (or dilute even more). 2 year old ibx trial, still no human instrument. And that metals deal? Sad, sad joke. Will there be a shareholder update from manny and marv about all the great things that are right around the corner? And how many interviews and promo videos for proulx this year? Will the trial ever get fully enrolled? Will it ever be completed? And if so, how long and how much cash for the next, larger trial? Sounds like manny, marv and proulx should be on trial themselves.
Ask .009 and volume zero. Under a penny and still no one wants this garbage. I guess most people actually do read the financial filings. Sorry marv.
Whoa, picked up some Low shares.
Look @ the market, what can you buy, Tesla, apple - good luck .
MHTX -No where to go but UP .
And mhtx drops below a penny. ibx can't be far behind as cash is running out. If only proulx could enroll patients in ibx trial as fast as he pumps out videos and interviews.
New video with IBX progress Bob Proulx put out a few days ago.
https://themarketherald.com.au/imagion-biosystems-asxibx-reports-positive-first-magsense-breast-cancer-clinical-data-2022-12-08/
My post said "it took 2 years into the study to produce this interim result which includes 6 people".
Do you know how many patients are in the 2nd cohort?
Did you read about the need for further studies on a broader scale?
Do you understand latest financials show less than 2 quarters of cash remaining and this includes the $2.5 million tax credit?
While there may be hope for the technology someday, there is no doubt that cash is running out and probably massive dilution on the way. None of these links to articles, interviews, and promotions say otherwise and the share price confirms it.
By the way, why no mention of manny and marv metals deal as mhtx struggles to hold above a penny and they have once again burned all the easy upfront cash? Silence speaks volumes.
For those saying "only 6 patients"... Did you not read the announcement? The first cohort was 6 patients and the second cohort has already received consistent results with the first.
That is good news. But here is an interesting piece of the article and one of the reasons why the stock is heading toward a penny:
And from the collaboration agreement between PAB and IBX signed 6 months ago...
Dr. James Campbell, Patrys’ CEO and Managing Director. “The potential for our deoxymab antibodies to home in on a range of different cancer types due to their affinity for DNA is one of the properties that makes them so unique and opens up a range of different clinical applications for their use. We are very excited to be further leveraging the cancer-targeting ability of deoxymabs by partnering with Imagion and its innovative MagSense® imaging technology to potentially develop new ways to visualise and diagnose cancer. This is the first of multiple potential applications of our deoxymab platform, and while our focus is on advancing our novel cancer therapeutics to the clinic we are actively engaged in business development efforts for the broader platform to leverage theunique attributes of deoxymabs.”
From a recent email reply of James Campbell, (CEO to Patrys Limited)...
"As well as the DX1 advances, investors should keep an eye on DX3, and the fact that we are already working with other companies to explore delivery of different payloads. This could generate some non-dilutive cash for us as we push forward into the clinic"
That's an interesting thought. I wonder how proulx will go about raising the share price (please, not more interviews and promo videos lol). He has shown no ability to do so in recent years and has also demonstrated complete disdain for shareholder value as he has diluted to over 1 billion shares and has done placements at very low prices. Issuing another 1/2 billion shares or even another billion would not seem to concern him at all.
Hopefully a reverse split wasn't the method to be used to "raise the sp". Companies like ibx typically see the post-reverse split price quickly return to the pre-split level and dilution run wild. Unfortunaely, it looks like that would be the only thing that could get ibx back to the 20 cent ipo level.
The real question should be how long can Lake Tahoe proulx remain as ceo without delivering a completed trial and an actual plan to increase shareholder value. Amazing how those who post here refuse to hold his feet to the fire; hopefully ibx bod will soon. This has been a multi-year disaster for investors and, more important, a travesty for all who could have benefited from this technology over the last 10 years.
yes, Proulx has managed to muck it all up with that difficult trial.
yes, dilution is coming, probably before end of 2nd quarter.
no, I don't believe 2 cents is coming, he will need to raise the sp before the dilution.
"Those who have knowledge, don't predict. Those who predict, don't have knowledge"
Looking thru latest quarterly report from ibx (now I see why no one else mentioned it), looks like they have less than 2 quarters worth of cash left and still haven't fully enrolled the 2 year old trial. Icing on the piece of crap cake - expenses are expected to increase going forward. Anyone denying that Lake Tahoe proulx has totally screwed up the trial and is running shareholder value into the ground deserves a big piece of that cake. Big time dilution is on the way and it's going to happen with a share price close to a penny. But hey, he sure does a lot of interviews and there certainly are a lot of links being posted. That'll get you 2 cents/share, at least for a while.
This article, published in May, shows Marie Zhang of Imagion Biosystems, San Diego as an author. Hover over her name in the list of authors. https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.2c00167
Not the one I am searching for...but appreciate the effort.
Looking for the "Optimizing Magnetic Nanoparticles for MR Contrast" that they tweeted. They teased us without showing what the results showed.
I think that they were referring to this one...
https://scholar.google.com/scholar?q=Imagion+biosystems++optimizing+magnetic+nanoparticles+for+mri+contrast.&hl=en&as_sdt=0&as_vis=1&oi=scholart#d=gs_qabs&t=1670004447048&u=%23p%3DnoV6NTOz1nsJ
Unfortunately crying won't make all those mhtx shares purchased at much higher prices profitable. But it is understandable how the buy low and watch it go lower and lower strategy could bring on the tears.
Does anyone have a link to this work and study?
Last week @ImagionBio's Director of Product Market Development, Mee Wa Wong, was pleased to present at the @VicBioImaging Network Meeting, covering our work on Optimizing Magnetic Nanoparticles for MR Contrast. #BioMedicalImaging #Nanoparticles #IBX pic.twitter.com/LwDoSsfCrf
— Imagion Biosystems (@imagionbio) December 1, 2022
Wow, that patent news took ibx down to .025
A few more proulx interviews and couple more great dd links and this should be sub-penny by the time new dilution hits.
Meanwhile, any updates on when that oh so important, almost 2 year old trial will be completed? How about when it will get 15 people enrolled? What a joke.
Imagion Biosystems seeks an international patent here...
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022060924
ibx .0255, the potential here is to become a sub-penny stock thanks to Lake Tahoe Proulx and his still not fully enrolled almost 2 year old trial.
ibx - great stock for those who love to watch their investment shrink and shrink and shrink. 20 cents and getting close to sub-penny. Shrewd.
I remain positive .
Could be, but no way it would make any sense to you.
Many new clinical trials? Sounds like they're going to need a lot of cash. Could that be why the share price keeps going lower and lower?
And what about their first trial? Now almost 2 years old and still can't get 15 people to enroll. Pitiful.
IBX has just posted, (an hour ago), that they are looking for a Program Director to guide them through the many new cancer clinical trials they are about to start...
https://www.linkedin.com/mwlite/jobs/view/3307998188?referenceId=nrN10YKZQEiLnNJlPMRzDQ%3D%3D&eBP=JOB_SEARCH_ORGANIC
Way to go Bob, ibx now .0265 and heading for sub-penny. How can anyone defend what this guy has done to shareholders? Even worse, the promises of this cancer fighting technology have been floated for over 10 years and still not even close to reality. Shame on these guys - manny, marv and proulx, lock them up.
ibx .028 - proulx must have another "nice" video on the way. This guy is as bad as marvin - just burn, burn, burn the cash and still can't get the 1st trial fully enrolled.
Going by history, the only one accumulating is you. You've been buying low and holding on as the stock goes lower and lower for years. No one else want this piece of crap or its spinoff ibx which is probably heading for under a penny. Good time for anyone who likes low prices that just keep going lower to buy I guess.
Terrible share price but someone is accumulating ~
Followers
|
84
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9560
|
Created
|
11/30/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |